159 related articles for article (PubMed ID: 31523957)
1. Neurotransmitter-Responsive Nanosensors for
Hsieh V; Okada S; Wei H; García-Álvarez I; Barandov A; Alvarado SR; Ohlendorf R; Fan J; Ortega A; Jasanoff A
J Am Chem Soc; 2019 Oct; 141(40):15751-15754. PubMed ID: 31523957
[TBL] [Abstract][Full Text] [Related]
2. Disruptive chemical doping in a ferritin-based iron oxide nanoparticle to decrease r2 and enhance detection with T1-weighted MRI.
Clavijo Jordan MV; Beeman SC; Baldelomar EJ; Bennett KM
Contrast Media Mol Imaging; 2014; 9(5):323-32. PubMed ID: 24764110
[TBL] [Abstract][Full Text] [Related]
3. A low-molecular-weight ditopic MRI probe for ratiometric sensing of zwitterionic amino acid neurotransmitters.
Toljić Đ; Angelovski G
Chem Commun (Camb); 2019 Oct; 55(79):11924-11927. PubMed ID: 31528965
[TBL] [Abstract][Full Text] [Related]
4. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
[TBL] [Abstract][Full Text] [Related]
5. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and T2-weighted magnetic resonance imaging.
Bae KH; Kim YB; Lee Y; Hwang J; Park H; Park TG
Bioconjug Chem; 2010 Mar; 21(3):505-12. PubMed ID: 20166678
[TBL] [Abstract][Full Text] [Related]
6. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.
Hobson NJ; Weng X; Siow B; Veiga C; Ashford M; Thanh NT; Schätzlein AG; Uchegbu IF
Nanomedicine (Lond); 2019 May; 14(9):1135-1152. PubMed ID: 31050589
[No Abstract] [Full Text] [Related]
7. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging.
Zottis AD; Beltrame JM; Lara LR; Costa TG; Feldhaus MJ; Pedrosa RC; Ourique F; de Campos CE; Isoppo Ede A; da Silva Miranda F; Szpoganicz B
Chem Commun (Camb); 2015 Jun; 51(56):11194-7. PubMed ID: 26073290
[TBL] [Abstract][Full Text] [Related]
8. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
10. The effects of particle shape and size on T2 relaxation in magnetic resonance imaging.
York JN; Albanese C; Rodriguez O; Le YC; Ackun-Farmmer M; Van Keuren E
J Biomed Nanotechnol; 2014 Nov; 10(11):3392-6. PubMed ID: 26000397
[TBL] [Abstract][Full Text] [Related]
11. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
12. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
13. A magnetic resonance tuning sensor for the MRI detection of biological targets.
Shin TH; Kang S; Park S; Choi JS; Kim PK; Cheon J
Nat Protoc; 2018 Nov; 13(11):2664-2684. PubMed ID: 30349049
[TBL] [Abstract][Full Text] [Related]
14. Strategies for sensing neurotransmitters with responsive MRI contrast agents.
Angelovski G; Tóth É
Chem Soc Rev; 2017 Jan; 46(2):324-336. PubMed ID: 28059423
[TBL] [Abstract][Full Text] [Related]
15. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
16. Peptide-Decorated Ultrasmall Superparamagnetic Nanoparticles as Active Targeting MRI Contrast Agents for Ovarian Tumors.
Yin J; Yao D; Yin G; Huang Z; Pu X
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41038-41050. PubMed ID: 31618000
[TBL] [Abstract][Full Text] [Related]
17. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
18. Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system.
Keasberry NA; Bañobre-López M; Wood C; Stasiuk GJ; Gallo J; Long NJ
Nanoscale; 2015 Oct; 7(38):16119-28. PubMed ID: 26371437
[TBL] [Abstract][Full Text] [Related]
19. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
[TBL] [Abstract][Full Text] [Related]
20. Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.
Yoo E; Cheng HA; Nardacci LE; Beaman DJ; Drinnan CT; Lee C; Fishbein KW; Spencer RG; Fisher OZ; Doiron AL
Colloids Surf B Biointerfaces; 2017 Oct; 158():578-588. PubMed ID: 28750340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
